HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew L Mammen Selected Research

Signal Recognition Particle

1/2022Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies.
1/2017Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
11/2016Spectrum of immune-mediated necrotizing myopathies and their treatments.
11/2014Necrotizing myopathies: beyond statins.
11/2012Myositis autoantibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew L Mammen Research Topics

Disease

56Myositis (Idiopathic Inflammatory Myopathies)
01/2022 - 01/2010
46Muscular Diseases (Myopathy)
01/2022 - 01/2010
26Dermatomyositis (Dermatopolymyositis)
01/2022 - 12/2009
10Inclusion Body Myositis
01/2022 - 02/2014
10Polymyositis
01/2022 - 01/2010
8Muscle Weakness
01/2022 - 01/2010
8Neoplasms (Cancer)
05/2021 - 06/2011
7Myotoxicity
01/2022 - 11/2010
6Antisynthetase syndrome
01/2022 - 11/2014
4Inflammation (Inflammations)
11/2017 - 01/2010
3Deglutition Disorders (Dysphagia)
01/2022 - 11/2017
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 01/2017
2Exanthema (Rash)
05/2021 - 12/2015
2Thymoma (Thymic Carcinoma)
10/2019 - 01/2019
2Disease Progression
10/2019 - 06/2015
2Muscular Dystrophies (Muscular Dystrophy)
01/2019 - 12/2017
2Autoimmune Diseases (Autoimmune Disease)
01/2018 - 01/2016
2Edema (Dropsy)
11/2017 - 03/2014
2Necrosis
11/2017 - 12/2015
2Fibrosis (Cirrhosis)
11/2017 - 10/2015
2Limb-girdle muscular dystrophy type 2A
01/2017 - 12/2015
2Mitochondrial Diseases (Mitochondrial Disease)
01/2017 - 08/2015
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2016 - 01/2016
1Crohn Disease (Crohn's Disease)
01/2022
1Ulcer
01/2022
1Amyopathic dermatomyositis
12/2021
1Acute-Phase Reaction
11/2021
1Cardiomyopathies (Cardiomyopathy)
10/2021
1COVID-19
03/2021
1Connective Tissue Diseases (Connective Tissue Disease)
11/2019
1Hyperlipidemias (Hyperlipidemia)
10/2019
1Pericarditis
01/2019
1Myasthenia Gravis
01/2019
1Glomerulonephritis
01/2019
1Mitochondrial Myopathies (Mitochondrial Myopathy)
03/2018
1Hemorrhagic Stroke
01/2018
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2018

Drug/Important Bio-Agent (IBA)

55AutoantibodiesIBA
01/2022 - 12/2009
24Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 09/2010
19Oxidoreductases (Dehydrogenase)IBA
01/2022 - 03/2011
15AntibodiesIBA
01/2022 - 06/2011
12Creatine Kinase (Creatine Phosphokinase)IBA
01/2022 - 09/2010
83-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
11/2017 - 03/2011
7EnzymesIBA
01/2022 - 03/2011
7Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2010
7Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA
01/2019 - 11/2012
5Signal Recognition ParticleIBA
01/2022 - 11/2012
4Coenzyme A (CoA)IBA
01/2022 - 08/2012
4RNA (Ribonucleic Acid)IBA
01/2022 - 01/2019
4InterferonsIBA
11/2021 - 06/2011
4AutoantigensIBA
01/2019 - 12/2009
35'-Nucleotidase (5' Nucleotidase)IBA
01/2022 - 01/2016
3Intravenous Immunoglobulins (IVIG)FDA Link
10/2021 - 10/2015
3Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
2ImmunosorbentsIBA
01/2022 - 03/2011
2glutaryl-coenzyme A (glutaryl-CoA)IBA
01/2022 - 03/2021
2Azathioprine (Imuran)FDA LinkGeneric
11/2019 - 09/2019
2B7-H1 AntigenIBA
10/2019 - 01/2019
2avelumabIBA
10/2019 - 01/2019
2SS-A antibodiesIBA
01/2019 - 12/2015
2Rituximab (Mabthera)FDA Link
01/2019 - 01/2018
2AntigensIBA
11/2018 - 08/2012
2Ligases (Synthetase)IBA
01/2017 - 06/2011
2SteroidsIBA
06/2015 - 06/2014
2Fructose-Bisphosphate Aldolase (Aldolase)IBA
03/2014 - 07/2012
2Biomarkers (Surrogate Marker)IBA
03/2014 - 07/2012
1CortactinIBA
01/2022
1FlagellinIBA
01/2022
1Mi-2 antibodiesIBA
01/2022
1imidazole mustard (BIC)IBA
01/2022
1Cadherins (E-Cadherin)IBA
01/2022
1Cell Adhesion MoleculesIBA
01/2022
1CytokinesIBA
11/2021
1humaninIBA
11/2021
1Protein Isoforms (Isoforms)IBA
11/2021
1ConnectinIBA
11/2021
1GlucocorticoidsIBA
10/2021
1UbiquitinIBA
05/2021
1DNA (Deoxyribonucleic Acid)IBA
03/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
09/2020
1Calcium-Calmodulin-Dependent Protein KinasesIBA
01/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
1Cell Adhesion Molecule-1IBA
01/2020
1apolipoprotein A-IV (apolipoprotein AIV)IBA
01/2020
1Prednisone (Sone)FDA LinkGeneric
11/2019
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
11/2019
1Proprotein Convertase 9IBA
10/2019
1PCSK9 InhibitorsIBA
10/2019
1Methotrexate (Mexate)FDA LinkGeneric
09/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2019
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2019
1pembrolizumabIBA
01/2019
1Muscle Proteins (Muscle Protein)IBA
01/2019
1Ustekinumab (CNTO 1275)FDA Link
01/2019
1CardiotoxinsIBA
01/2019
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
01/2019
1Mitochondrial DNA (mtDNA)IBA
03/2018

Therapy/Procedure

7Therapeutics
11/2021 - 03/2014
3Immunotherapy
01/2019 - 12/2017
1Self-Help Devices (Assistive Technology)
01/2022